1. Home
  2. ALLR vs LOCL Comparison

ALLR vs LOCL Comparison

Compare ALLR & LOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$0.79

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Logo Local Bounti Corporation

LOCL

Local Bounti Corporation

HOLD

Current Price

$0.66

Market Cap

21.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLR
LOCL
Founded
2004
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
19.3M
21.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
ALLR
LOCL
Price
$0.79
$0.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 136.5K
15.3K
Earning Date
11-13-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 60.33
EPS
★ N/A
N/A
Revenue
$320,000.00
★ $48,365,000.00
Revenue This Year
N/A
$93.32
Revenue Next Year
N/A
$25.13
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 26.82
52 Week Low
$0.77
$0.60
52 Week High
$1.84
$3.13

Technical Indicators

Market Signals
Indicator
ALLR
LOCL
Relative Strength Index (RSI) 38.05 32.32
Support Level N/A $0.60
Resistance Level $1.45 $1.23
Average True Range (ATR) 0.09 0.07
MACD -0.01 -0.01
Stochastic Oscillator 3.70 26.56

Price Performance

Historical Comparison
ALLR
LOCL

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

About LOCL Local Bounti Corporation

Local Bounti Corp is a controlled environment agriculture company. The business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides. The products of the company include living lettuce, leafy greens, herbs, and others.

Share on Social Networks: